Tiziana Life Sciences seeks FDA orphan drug status for foralumab in MSASep 30Regulatory milestoneforalumabTiziana Life Sciences LTD
Tiziana doses first ALS patients with intranasal foralumab in BANYAN trialSep 28Trial updateforalumabTiziana Life Sciences LTD
Tiziana completes last patient visit in Phase 2a INFORM-MS foralumab trialSep 21Clinical readoutforalumabTiziana Life Sciences LTD
Tiziana presents BANYAN trial poster on intranasal foralumab in ALS at conferenceAug 24Clinical readoutforalumabTiziana Life Sciences LTD
Tiziana registers Phase 2a "BANYAN" trial of nasal foralumab in ALSJul 7Trial updateforalumabTiziana Life Sciences LTD
Sign inSign in